Methods for preventing or treating allergy by administering an IL-4R antagonist
US11771743B2 · kind B2 · utility
1Cited by
49References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2017 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Feb 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for preventing or treating allergy. Also provided are methods for reducing the susceptibility to an allergen in a subject in need thereof. In certain embodiments, the subject has a disease or disorder selected from the group consisting of atopic dermatitis, asthma, allergic rhinitis, and eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.